Cyclerion Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Cyclerion Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2019 to Q2 2024.
  • Cyclerion Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 400 %, a 121% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 400 +219 +121% Jun 30, 2024
Q1 2024 287 +58.7 +25.7% Mar 31, 2024
Q4 2023 197 -115 -36.9% Dec 31, 2023
Q3 2023 179 -210 -54.1% Sep 30, 2023
Q2 2023 181 -282 -60.9% Jun 30, 2023
Q1 2023 228 -326 -58.8% Mar 31, 2023
Q4 2022 313 -197 -38.7% Dec 31, 2022
Q3 2022 389 -69.1 -15.1% Sep 30, 2022
Q2 2022 463 +33.2 +7.72% Jun 30, 2022
Q1 2022 554 +180 +48.3% Mar 31, 2022
Q4 2021 510 +81.3 +19% Dec 31, 2021
Q3 2021 458 -30.4 -6.22% Sep 30, 2021
Q2 2021 430 -115 -21.2% Jun 30, 2021
Q1 2021 373 -244 -39.6% Mar 31, 2021
Q4 2020 428 -50.6 -10.6% Dec 31, 2020
Q3 2020 489 +139 +39.6% Sep 30, 2020
Q2 2020 546 Jun 30, 2020
Q1 2020 618 Mar 31, 2020
Q4 2019 479 Dec 31, 2019
Q3 2019 350 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.